Resveratrol aids in reducing metastasis and EMT processes within cancer cells as it acts as an aberrant signalling pathway inhibitor [56, 60], promotes the transcription of epithelial marker E‐cadherin [77], and reduces mesenchymal marker expression such as vimentin, N‐cadherin, and slug [72]. Here, CDH1 is linked to cancer.